Teleflex will present at the Raymond James Conference on March 4, 2025, with a live audio webcast available.
Quiver AI Summary
Teleflex Incorporated announced that its management will present at the Raymond James & Associates 46th Annual Institutional Investors Conference in Orlando, FL, on March 4, 2025, at 3:25 p.m. (ET). The presentation will be accessible via a live audio webcast and accompanying slides on the Teleflex investor website. Teleflex, a global healthcare technology provider, aims to enhance health and quality of life through innovative medical solutions across various therapeutic areas including anesthesia, emergency medicine, and urology, among others. They emphasize their commitment to shaping the future of healthcare with trusted product brands. For further details, interested parties can visit the Teleflex website or contact their Investor Relations team.
Potential Positives
- Teleflex will present at a major investment conference, providing an opportunity to engage with institutional investors and enhance visibility.
- The live audio webcast allows for broader access to the presentation, potentially attracting interest from additional stakeholders.
- The company emphasizes its commitment to innovation and improving healthcare, which reinforces its brand message and corporate purpose.
Potential Negatives
- There are no specific details about new product launches or innovations being presented at the conference, which may signal a stagnation in growth or development.
FAQ
What is the date and time of Teleflex's presentation at the conference?
Teleflex's presentation is scheduled for March 4, 2025, at 3:25 p.m. (ET).
Where will the Teleflex conference presentation take place?
The presentation will be held at the JW Marriott Grande Lakes, Orlando, FL.
How can I access the Teleflex conference webcast?
A live audio webcast of the conference presentation will be available on the Teleflex investor section at teleflex.com.
What sectors does Teleflex focus on?
Teleflex offers solutions in anesthesia, emergency medicine, interventional cardiology, surgical, vascular access, and urology.
Who is the contact person for Teleflex investor relations?
Lawrence Keusch is the Vice President of Investor Relations; he can be reached at [email protected].
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$TFX Hedge Fund Activity
We have seen 246 institutional investors add shares of $TFX stock to their portfolio, and 306 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MILLENNIUM MANAGEMENT LLC removed 494,147 shares (-66.4%) from their portfolio in Q4 2024, for an estimated $87,948,283
- POINT72 ASSET MANAGEMENT, L.P. removed 407,442 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $72,516,527
- INVESCO LTD. added 347,003 shares (+48.1%) to their portfolio in Q4 2024, for an estimated $61,759,593
- DIAMOND HILL CAPITAL MANAGEMENT INC added 262,364 shares (+inf%) to their portfolio in Q4 2024, for an estimated $46,695,544
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 261,279 shares (+4.4%) to their portfolio in Q4 2024, for an estimated $46,502,436
- MAGNETAR FINANCIAL LLC added 215,961 shares (+105.2%) to their portfolio in Q4 2024, for an estimated $38,436,738
- CEREDEX VALUE ADVISORS LLC removed 199,975 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $35,591,550
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
WAYNE, Pa., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Management of Teleflex Incorporated (NYSE: TFX), will be presenting at the Raymond James & Associates 46th Annual Institutional Investors Conference at the JW Marriott Grande Lakes, Orlando, FL, on Tuesday, March 4, 2025, at 3:25 p.m. (ET).
A live audio webcast of the conference presentation, along with the accompanying slide presentation, will be available on the investor section of the Teleflex website at teleflex.com .
About Teleflex Incorporated
As a global provider of medical technologies, Teleflex is driven by our purpose to improve the health and quality of people’s lives. Through our vision to become the most trusted partner in healthcare, we offer a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. We believe that the potential of great people, purpose driven innovation, and world-class products can shape the future direction of healthcare.
Teleflex is the home of Arrow™, Barrigel™, Deknatel™, LMA™, Pilling™, QuikClot™, Rüsch™, UroLift™ and Weck™ – trusted brands united by a common sense of purpose.
At Teleflex, we are empowering the future of healthcare. For more information, please visit teleflex.com.
Contacts:
Teleflex
Lawrence Keusch
Vice President, Investor Relations and Strategy Development
[email protected]
610-948-2836
